Senator Chuck Grassley's Public Statements

Office: U.S. Senate (IA) - Sr, Republican
Issue Category
Keyword Search
11/23/16 Q&A: Supporting Small Business 11/21/16 EpiPen Maker Declines to Testify at Oversight Hearing Following Agency Refusal to Testify 11/15/16 Letter to the Honorable Mary Jo White, Chair of the Securities and Exchange Commission - Call for Information as to Whether the Securities and Exchange Commission is Looking into Mylan's Press Release in Order to Determine If It Was Materially Misleading 11/07/16 Letter to the Honorable Edith Ramirez, Chairwoman of the Federal Trade Commission - Regarding Mylan's Engagement in Potential Anti-Competitive Practices 11/02/16 Letter to Ms. Renata Hesse, Department of Justice, Antitrust Division - Scrutinize Bayer-Monsanto 10/27/16 Letter to Ren Jianxin, Chairman, China National Chemical Corporation - Answers to Outstanding Questions from ChemChina on Merger 10/26/16 Grassley to Hold Judiciary Committee Hearing to Explore Potential Mylan-Justice Department Settlement Over EpiPens 10/24/16 Grassley Statement on Proposed AT&T-Time Warner Deal 10/04/16 The Gazette - Sen. Chuck Grassley Continues to Press Mylan Over EpiPen Cost Increases 9/20/16 USA Today - Agriculture Executives Defend Merger 'Tsunami' 9/09/16 Grassley on Mylan's Response on EpiPen Price Increases 9/09/16 Grassley: ATF Must Get Serious about its Undercover Storefront Operations 8/31/16 Letter to Andrew Slavitt, Acting Administrator, Centers for Medicare and Medicaid Services - Provide Information on the Effects of Mylan's Price Increases on Government Prescription Drug Costs 8/30/16 Letter to John Kerry, Secretary of the Dept. of State - Gunsmiths Regulations 8/29/16 Letter to the Honorable John Kerry, Secretary of the Department of State - In Defense of the Second Amendment and Small Businesses 7/22/16 Q&A: Protecting Innovation and Trade Secrets 7/15/16 Grassley Raises Awareness of Anti-Counterfeiting Efforts 7/14/16 Tyson Offer on Cherokee Plant is Good News for Community, Grassley Says 7/12/16 Grassley: Food Security is National Security 6/30/16 Grassley Welcomes Latest Data on Drug, Device Company Payments to Doctors, Teaching Hospitals 6/26/16 Letter to Andrew Slavitt, Acting Administrator at the Centers for Medicare & Medicaid Services - Grassley Presses the Administration on Reasons for Alarming Increase in Medicare Catastrophic Drug Spending 6/23/16 GMO Labeling Bill Agreement Reached 6/21/16 Foreign Sovereign Immunities Act 6/21/16 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on The CREATES Act: Ending Regulatory Abuse, Protecting Consumers, and Ensuring Drug Price Competition 6/15/16 Statements on Introduced Bills and Joint Resolutions 5/23/16 Senators Commit to Oversight of Consolidation in Agri-Chem Industry 5/11/16 Hearing of the Privacy, Technology and the Law Subcommittee of the Senate Judiciary Committee - Chairman Grassley's Statement on "Examining the Proposed FCC Privacy Rules" 4/27/16 Hearing of the Senate Judiciary Committee - Chairman Grassley's Opening Statement on "Counterfeits and Their Impact on Consumer Health and Safety" 4/26/16 Energy and Water Development and Related Agencies Appropriations Act, 4/11/16 Letter to MIchael Froman, U.S. Trade Representative and the Hon. Penny Pritzker, Secretary of Commerce - Call for Effective Trade Enforcement to Combat Market-Distorting Policies 4/04/16 Defend Trade Secrets Act of 2015 3/28/16 Letter to Administrator McCarthy - Urging EPA to Release Strong Renewable Fuel Standard to Support Homegrown Ethanol Production 2/03/16 Energy Policy Modernization Act of 2015 2/02/16 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, "The failures and future of the EB-5 Regional Center program: Can it be fixed?" 1/21/16 Letter to the Health Care and Patient Community - Request Comment on Sovaldi Report 12/02/15 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on Protecting Trade Secrets: the Impact of Trade Secret Theft on American Competitiveness and Potential Solutions to Remedy This Harm 12/01/15 Wyden-Grassley Sovaldi Investigation Finds Revenue-Driven Pricing Strategy Behind $84,000 Hepatitis Drug 9/22/15 Hearing of the Subcommittee on Antitrust, Competition Policy and Consumer Rights of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Examining Consolidation in the Health Insurance Industry and its Impact on Consumers 9/09/15 Klobuchar, Grassley Renew Efforts to Crack Down on Anti-Competitive Pay-for-Delay Pharmaceutical Deals 7/30/15 Grassley Welcomes Highway, Veterans Provisions Passed Today 7/16/15 Hearing of the Senate Judiciary Committee - Executive Business Meeting 7/09/15 Grassley Reaction to the Denial of a Disaster Declaration on Avian Flu Outbreak 7/07/15 Grassley, Heitkamp, Boustany, and Thompson Introduce Health Reimbursement Arrangement (HRA) Bills 6/25/15 Statements on Introduced Bills and Joint Resolutions 6/25/15 Senate, House Co-Chairs Relaunch Congressional Trademark Caucus 6/17/15 Grassley, Leahy Introduce Legislation to Protect Whistleblowers in Criminal Antitrust Cases 6/10/15 Letter to Jennifer Shasky Calvery, Director of the Financial Crimes Enforcement Network - Protection of the Financial System from Criminal Exploitation 6/09/15 Grassley: FTC to Review Potentially Deceptive Hotel Booking Sites 6/04/15 PATENT Act Clears Committee with Overwhelming Vote of Support 5/26/15 Letter to Edith Ramirez, Chairwoman of the Federal Trade Commission - Third Party Online Hotel Booking Services

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.